182 related articles for article (PubMed ID: 32993745)
21. Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: Time to incorporate laparoscopic assessment into the standard of care.
Gómez-Hidalgo NR; Martinez-Cannon BA; Nick AM; Lu KH; Sood AK; Coleman RL; Ramirez PT
Gynecol Oncol; 2015 Jun; 137(3):553-8. PubMed ID: 25827290
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma.
Gockley AA; Fiascone S; Hicks Courant K; Pepin K; Del Carmen M; Clark RM; Goldberg J; Horowitz N; Berkowitz R; Worley M
Int J Gynecol Cancer; 2019 Mar; 29(3):585-592. PubMed ID: 30833444
[TBL] [Abstract][Full Text] [Related]
23. Poor anaerobic threshold and VO
Element K; Asher V; Bali A; Abdul S; Gomez D; Tou S; Curtis R; Low J; Phillips A
J Obstet Gynaecol; 2022 Feb; 42(2):294-300. PubMed ID: 33938364
[TBL] [Abstract][Full Text] [Related]
24. A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses.
Bogani G; Tagliabue E; Signorelli M; Ditto A; Martinelli F; Chiappa V; Mosca L; Sabatucci I; Leone Roberti Maggiore U; Lorusso D; Raspagliesi F
J Gynecol Oncol; 2018 May; 29(3):e40. PubMed ID: 29533023
[TBL] [Abstract][Full Text] [Related]
25. Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian Cancer.
Fleming ND; Nick AM; Coleman RL; Westin SN; Ramirez PT; Soliman PT; Fellman B; Meyer LA; Schmeler KM; Lu KH; Sood AK
Obstet Gynecol; 2018 Sep; 132(3):545-554. PubMed ID: 30095787
[TBL] [Abstract][Full Text] [Related]
26. Proposal for selection criteria of secondary cytoreductive surgery in recurrent epithelial ovarian, tubal, and peritoneal cancers.
Minaguchi T; Satoh T; Matsumoto K; Sakurai M; Ochi H; Onuki M; Oki A; Yoshikawa H
Int J Clin Oncol; 2016 Jun; 21(3):573-9. PubMed ID: 26475355
[TBL] [Abstract][Full Text] [Related]
27. A framework for a personalized surgical approach to ovarian cancer.
Nick AM; Coleman RL; Ramirez PT; Sood AK
Nat Rev Clin Oncol; 2015 Apr; 12(4):239-45. PubMed ID: 25707631
[TBL] [Abstract][Full Text] [Related]
28. Using a machine learning algorithm to predict outcome of primary cytoreductive surgery in advanced ovarian cancer.
Piedimonte S; Erdman L; So D; Bernardini MQ; Ferguson SE; Laframboise S; Bouchard Fortier G; Cybulska P; May T; Hogen L
J Surg Oncol; 2023 Mar; 127(3):465-472. PubMed ID: 36350138
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic Resection as Part of Cytoreductive Surgery in Advanced-stage and Recurrent Epithelial Ovarian Cancer--A Single-center Experience.
Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
Anticancer Res; 2015 Jul; 35(7):4125-9. PubMed ID: 26124365
[TBL] [Abstract][Full Text] [Related]
30. Surgical complexity score and role of laparoscopy in women with advanced ovarian cancer treated with neoadjuvant chemotherapy.
Davidson BA; Broadwater G; Crim A; Boccacio R; Bixel K; Backes F; Previs RA; Salinaro J; Salani R; Moore K; Secord AA
Gynecol Oncol; 2019 Mar; 152(3):554-559. PubMed ID: 30558972
[TBL] [Abstract][Full Text] [Related]
31. A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience.
Ghisoni E; Katsaros D; Maggiorotto F; Aglietta M; Vaira M; De Simone M; Mittica G; Giannone G; Robella M; Genta S; Lucchino F; Marocco F; Borella F; Valabrega G; Ponzone R
J Ovarian Res; 2018 May; 11(1):42. PubMed ID: 29843747
[TBL] [Abstract][Full Text] [Related]
32. Positive DESKTOP and Tian Scores Systems Are Adequate to Predict Optimal (R0) Secondary Debulking Surgery in Ovarian Cancer, But a Negative Score Does Not Preclude Secondary Surgery.
Laga T; Lambrechts S; Laenen A; Van Nieuwenhuysen E; Han SN; Vergote I
Int J Gynecol Cancer; 2018 May; 28(4):721-728. PubMed ID: 29561300
[TBL] [Abstract][Full Text] [Related]
33. A pre-operative predictive score to evaluate the feasibility of complete cytoreductive surgery in patients with epithelial ovarian cancer.
Chesnais M; Lecuru F; Mimouni M; Ngo C; Fauconnier A; Huchon C
PLoS One; 2017; 12(11):e0187245. PubMed ID: 29117194
[TBL] [Abstract][Full Text] [Related]
34. A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study.
Feng Z; Wen H; Jiang Z; Liu S; Ju X; Chen X; Xia L; Xu J; Bi R; Wu X
J Gynecol Oncol; 2018 Sep; 29(5):e65. PubMed ID: 30022629
[TBL] [Abstract][Full Text] [Related]
35. Primary debulking surgery of the upper abdomen and the diaphragm, with a plasma device surgery system, for advanced ovarian cancer.
Cordeiro Vidal G; Babin G; Querleu D; Guyon F
Gynecol Oncol; 2017 Jan; 144(1):223-224. PubMed ID: 27836207
[TBL] [Abstract][Full Text] [Related]
36. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.
Manning-Geist BL; Hicks-Courant K; Gockley AA; Clark RM; Del Carmen MG; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
Am J Obstet Gynecol; 2019 Oct; 221(4):326.e1-326.e7. PubMed ID: 31082382
[TBL] [Abstract][Full Text] [Related]
37. Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience.
Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
Anticancer Res; 2015 Oct; 35(10):5649-54. PubMed ID: 26408738
[TBL] [Abstract][Full Text] [Related]
38. The Prognostic Role of Optimal Cytoreduction in Advanced, Bowel Infiltrating Ovarian Cancer.
Bachmann R; Rothmund R; Krämer B; Brucker SY; Königsrainer A; Königsrainer I; Beckert S; Staebler A; NguyenHuu P; Grischke E; Wallwiener D; Bachmann C
J Invest Surg; 2015 Jun; 28(3):160-6. PubMed ID: 25565126
[TBL] [Abstract][Full Text] [Related]
39. A radical approach to achieve complete cytoreductive surgery improve survival of patients with advanced ovarian cancer.
Liberale G; Pop CF; Polastro L; Kerger J; Moreau M; Chintinne M; Larsimont D; Nogaret JM; Veys I
J Visc Surg; 2020 Apr; 157(2):79-86. PubMed ID: 31837942
[TBL] [Abstract][Full Text] [Related]
40. Molecular and phenotypic characteristics influencing the degree of cytoreduction in high-grade serous ovarian carcinomas.
Torkildsen CF; Thomsen LCV; Sande RK; Krakstad C; Stefansson I; Lamark EK; Knappskog S; Bjørge L
Cancer Med; 2023 Jul; 12(13):14183-14195. PubMed ID: 37191035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
